Get the Stockscreener App
50.05
3.79%
-1.97
Disc Medicine Inc stock is traded at $50.05, with a volume of 407.29K.
It is down -3.79% in the last 24 hours and up +4.08% over the past month.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
See More
Previous Close:
$52.02
Open:
$51.11
24h Volume:
407.29K
Relative Volume:
0.94
Market Cap:
$1.84B
Revenue:
-
Net Income/Loss:
$-91.00M
P/E Ratio:
-13.64
EPS:
-3.67
Net Cash Flow:
$-74.38M
1W Performance:
-5.69%
1M Performance:
+4.08%
6M Performance:
-23.00%
1Y Performance:
+11.57%
1-Day Range:
$50.03
$51.79
1-Week Range:
$49.80
$54.13
52-Week Range:
$30.82
$68.73
Disc Medicine Inc Stock (IRON) Company Profile
Name
Disc Medicine Inc
Sector
Industry
Phone
(617) 674-9274
Address
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
50.05 | 1.84B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.99 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
508.86 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.71 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
540.71 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
254.09 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-11-25 | Resumed | Raymond James | Strong Buy |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-04-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-23-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-01-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-19-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-09-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jun-07-23 | Initiated | H.C. Wainwright | Buy |
| May-17-23 | Initiated | Raymond James | Outperform |
| Apr-28-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-21-23 | Initiated | Stifel | Buy |
| Apr-20-23 | Initiated | Morgan Stanley | Overweight |
| Mar-23-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-28-23 | Initiated | SVB Securities | Outperform |
View All
Disc Medicine Inc Stock (IRON) Latest News
Analysts Offer Predictions for Disc Medicine Q2 Earnings - Defense World
Raymond James Resumes Coverage on Disc Medicine (IRON) With a Strong Buy Rating - MSN
Disc Medicine stock price target maintained at $118 by H.C. Wainwright - Investing.com
Disc Medicine (IRON) Maintains Buy Rating and Price Target | IRO - GuruFocus
Disc Medicine (IRON) Maintains Buy Rating and Price Target | IRON Stock News - GuruFocus
Disc Medicine’s (IRON) Outperform Rating Reaffirmed at Wedbush - Defense World
First Week of December 19th Options Trading For Disc Medicine (IRON) - Nasdaq
Long Term Trading Analysis for (IRON) - news.stocktradersdaily.com
Disc Medicine shareholders vote on executive pay and board members By Investing.com - Investing.com Canada
Disc Medicine shareholders vote on executive pay and board members - Investing.com Australia
Disc Medicine Holds 2025 Annual Stockholders Meeting - TipRanks
Disc Medicine Presents Positive Clinical Data Updates Across Por - GuruFocus
Disc Medicine (IRON) Highlights Research Advances at EHA 2025 | - GuruFocus
Disc Medicine reports positive data from clinical programs at EHA By Investing.com - Investing.com South Africa
Disc Medicine Highlights Positive Clinical Data for Bitopertin, DISC-0974, and DISC-3405 at EHA 2025; Management to Host Corporate Update Call - Nasdaq
Disc Medicine Presents Positive Clinical Data Updates - GlobeNewswire
Disc Medicine Reports Breakthrough Clinical Data Across 3 Blood Disease Programs | IRON Stock News - Stock Titan
Disc Medicine (NASDAQ:IRON) Now Covered by Analysts at Raymond James - Defense World
10 Best Small-Cap Growth Stocks to Buy According to Analysts - Insider Monkey
IRON Stock: Disc Medicine (IRON) Receives Strong Buy Rating from - GuruFocus
California State Teachers Retirement System Sells 1,436 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Cantor Fitzgerald Estimates Disc Medicine FY2026 Earnings - Defense World
Disc Medicine (IRON) Rated Strong Buy by Raymond James | IRON St - GuruFocus
Disc Medicine chief medical officer sells $149,800 in stock By Investing.com - Investing.com India
Insider Sell: William Savage Sells Shares of Disc Medicine Inc (IRON) - GuruFocus
Disc Medicine chief medical officer sells $149,800 in stock - Investing.com
Millennium Management LLC Buys Shares of 7,879 Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Ameriprise Financial Inc. Invests $335,000 in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Bank of America Corp DE Reduces Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of “Buy” from Analysts - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Shares Sold by Nuveen Asset Management LLC - Defense World
Disc Medicine to Participate in Upcoming Investor Conferences - GlobeNewswire
Disc Medicine Sets Double Conference Appearance: Jefferies and Goldman Sachs Healthcare Events - Stock Titan
BNP Paribas Financial Markets Invests $324,000 in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Stock Position Raised by Deutsche Bank AG - Defense World
Medical Marijuana (OTCMKTS:MJNA) Stock Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Disc Medicine Shows Improved Relative Price Performance; Still Shy Of Benchmark - MSN
Disc Medicine’s chief medical officer sells $334,128 in stock By Investing.com - Investing.com Canada
Disc Medicine’s chief medical officer sells $334,128 in stock - Investing.com
Porphyria Pipeline 2025: Groundbreaking Clinical - openPR.com
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Northern Trust Corp - Defense World
Commit To Buy Disc Medicine At $35, Earn 14.1% Annualized Using Options - Nasdaq
Disc Medicine Announces Multiple Presentations Across Portfolio - GuruFocus
Disc Medicine, Inc. to Present Key Data from Hematology Portfolio at EHA 2025 Congress - Nasdaq
Disc Medicine Announces Multiple Presentations Across - GlobeNewswire
Disc Medicine Reveals First Disease-Modifying EPP Treatment Data Among 6 Clinical Updates at EHA 2025 - Stock Titan
BMO Capital Markets Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock - Defense World
Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference - The Manila Times
Disc Medicine Inc Stock (IRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):